Peregrine Pharmaceuticals (NASDAQ:PPHM) Receives Media Impact Score of 0.02

Peregrine Pharmaceuticals has a consensus rating of "Hold" and an average price target of $0.94. Its book value per share for the most recent quarter is $0.15 while its price to book ratio for the same period is 4.22, as for as the company's cash per share for the most recent quarter is $0.15, however its price to cash per share ratio for the same period is 4.34. The return on assets (ROA) (aka return on total assets, return on average assets), is one of the most widely used profitability ratios because it is related to both profit margin and asset turnover, and shows the rate of return for both creditors and investors of the company. Burt Wealth Advsr has 2,000 shares for 0% of their portfolio. (NASDAQ:PPHM)'s stock about -11.85% from the 50-day high and 12.26% away from the 50-day low.

The stock's 50 day moving average is 0.57 and its 200 day moving average is 0.51. Consensus earnings estimates are far from ideal, but they are watched by many investors and play an important role in measuring the appropriate valuation for a stock. This rating uses a scale from 1 to 5. (PPHM) has an Analysts' Mean Recommendation of 1.5, according to data compiled by Finviz. They now have a Dollars 0.5 price target on the stock.

Peregrine Pharma New (NASDAQ:PPHM)'s revenue estimates for the current quarter are $22.6 Million according to 1 number of analysts, for the current quarter the company has high revenue estimates of $22.6 Million in contradiction of low revenue estimates of $22.6 Million. For the last quarter, the stock has performed -21.57%. (NASDAQ:AAPL) stake by 10,072 shares and now owns 211,824 shares.

Checking in on some valuation rankings, Peregrine Pharmaceuticals, Inc. The company reported revenue of $0 in the same period a year ago. Its sales stood at -8.40% a year on average in the period of last five years. The stock increased 0.36% or $0.002 on July 3, reaching $0.61.

A price target is the projected price level of a financial security stated by an investment analyst.

Roth Capital "Downgrades" Peregrine Pharma New (NASDAQ:PPHM) in a research note issued to investors on 2/26/16 to Neutral. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company.

A large surprise factor in either direction typically can lead to a significant swing in the stock price in the hours and days after the report. Regardless, closing prices are a useful tool that investors use to quantify changes in stock prices over time.

When we see the company's Volatility, it now has a monthly volatility of 5.61% and weekly volatility of 5.57%. It has a 36-month beta of 2.54, so you might be in for a bumpy ride. Blackrock Institutional Na owns 4.24M shares.

The relative strength index or RSI highlights overbought (above 70) and oversold (below 30) areas. The debt-to-equity ratio (D/E) was recorded at 0.00.

Consequently Peregrine Pharma New (NASDAQ:PPHM)'s weekly and monthly volatility is 5.57%, 5.61% respectively.

We can now take a quick look at some historical stock price index data.

Analysts await Peregrine Pharmaceuticals (NASDAQ:PPHM) to report earnings on July, 13. Analysts are forecasting earnings of $-0.01 on a per share basis this quarter.

Zacks offers analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations. A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range.

Like this



08 July 2017
Thunder Agree to Deal With Raymond Felton
Paul George is obviously a big help (you can stagger him and Westbrook at times), but also they have added depth. The deal is reportedly for one-year and worth the veteran's minimum of $2.3 million.

08 July 2017
Cavaliers add Jeff Green, could land sixth man Jamal Crawford
With the Hawks apparently entering a rebuilding era, Crawford will be able to sign with a contending team if he's not claimed. The veteran guard had played in Atlanta from 2009-11 and was the league's top sixth man in 2010.

08 July 2017
"Unspecified threats" from passenger force flight to return to Montreal
They were given a conditional discharge and ordered to pay a fine of $500 each and to pay $7,500 in restitution to Sunwing. Nassios posted this image, showing his Sunwing window seat, just prior to the plane's departure from the Montreal airport.

08 July 2017
Investors Catching Stocks AVEO Pharmaceuticals, Inc. (AVEO)
ValuEngine lowered AVEO Pharmaceuticals from a "sell" rating to a "strong sell" rating in a research note on Friday, June 2nd. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover AVEO having a buy-equivalent rating.

08 July 2017
Border row: China says India has 'ulterior motives'
Beijing and Thimphu claim Doklam, where the Chinese were stopped by the Indian Army from building a road. Any attempt to unilaterally determine the trijunction is a violation of the convention.

08 July 2017
Eli Lilly and Company (NYSE:LLY) Valuation Review & Update
Therefore 76% are positive. 11,162 Eli Lilly and Co (NYSE:LLY) shares with value of $861,085 were sold by Rice Derica W. According to Thomson Reuters, sell-side analysts are predicting a consensus target price of $17.41 on company stock.

08 July 2017
Marco Investment Management LLC Holds Position in Silicon Motion Technology Corporation (SIMO)
Analysts await Silicon Motion Technology Corp. (ADR) (NASDAQ: SIMO ) has risen 21.46% since July 7, 2016 and is uptrending. Moreover, Livforsakringsbolaget Skandia Omsesidigt has 0.12% invested in Stryker Corporation (NYSE:SYK) for 19,297 shares.

08 July 2017
Pier 1 Imports, Inc. (NYSE:PIR) Under Analyst Spotlight
The company's current price-earnings ratio amounts to 12.32 times earnings, below the average P/E ratio of 26.40 times earnings. The specialty retailer reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.01.

08 July 2017
Risky driving charge approved against Nanaimo RCMP officer
The case was investigated by the Independent Investigation Office (IIO), which subsequently submitted a report to Crown counsel. Prosecution Service announced it had approved a charge of one count of risky driving causing bodily harm.

08 July 2017
GOP senator: Trump needs to 'apply pain' to Russian Federation
Clapper said it was possible others might have meddled, but contended that there "wasn't any evidence" to support that claim. In early January, the DNI issued a declassified version of the intelligence community assessment.